Pure Global AI
UMIN000050323Enrolling by invitation

Verification of therapeutic effects and prognosis by mesenchymal stem cell therapy in regenerative medicine and neuro rehabilitation for stroke patients

Fukunagakinen ClinicUniversity Hospital Medical Information NetworkdeviceDevice trial
VerifiedUniversity Hospital Medical Information Network
Study focus
Disease/Condition
stroke
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Fukunagakinen Clinic
Location
Japan
Timeline & enrollment
Phase
N/A
Start date
Mar 15, 2023
End date
N/A
ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000050323
Type
Device Trial
About this record

Access comprehensive clinical trial information for UMIN000050323 through Pure Global AI's free database. This phase not specified trial is sponsored by Fukunagakinen Clinic and is currently Enrolling by invitation. The study focuses on stroke.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.